Get the Stockscreener App
0.5047
5.41%
0.0259
After Hours:
.51
0.0053
+1.05%
Century Therapeutics Inc stock is traded at $0.5047, with a volume of 547.61K.
It is up +5.41% in the last 24 hours and down -9.55% over the past month.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
See More
Previous Close:
$0.4788
Open:
$0.49
24h Volume:
547.61K
Relative Volume:
0.60
Market Cap:
$43.60M
Revenue:
$2.24M
Net Income/Loss:
$-136.67M
P/E Ratio:
-0.2204
EPS:
-2.29
Net Cash Flow:
$-102.08M
1W Performance:
+2.64%
1M Performance:
-9.55%
6M Performance:
-16.94%
1Y Performance:
-64.95%
1-Day Range:
$0.4862
$0.5098
1-Week Range:
$0.4613
$0.5098
52-Week Range:
$0.3418
$1.8599
Century Therapeutics Inc Stock (IPSC) Company Profile
Name
Century Therapeutics Inc
Sector
Industry
Phone
215-981-4000
Address
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Compare IPSC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.5047 | 41.36M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-28-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-27-22 | Initiated | Chardan Capital Markets | Buy |
| Oct-31-22 | Initiated | Guggenheim | Buy |
| Oct-10-22 | Initiated | Canaccord Genuity | Buy |
| May-23-22 | Initiated | H.C. Wainwright | Buy |
| May-12-22 | Initiated | William Blair | Mkt Perform |
| Jul-13-21 | Initiated | BofA Securities | Buy |
| Jul-13-21 | Initiated | JP Morgan | Overweight |
| Jul-13-21 | Initiated | Piper Sandler | Overweight |
View All
Century Therapeutics Inc Stock (IPSC) Latest News
Price action breakdown for Century Therapeutics Inc.July 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Is Century Therapeutics Inc. undervalued by DCF analysis2025 Risk Factors & Weekly Stock Breakout Alerts - خودرو بانک
What is the long term forecast for Century Therapeutics Inc. stockTrade Volume Report & Daily Risk Controlled Trade Plans - خودرو بانک
Downgrade Watch: What is the PEG ratio of Century Therapeutics Inc.July 2025 Weekly Recap & Weekly Stock Breakout Alerts - خودرو بانک
Century Therapeutics Granted Nasdaq Compliance Extension - MSN
Will Century Therapeutics Inc. outperform tech stocksJuly 2025 Action & AI Optimized Trade Strategies - 시사인 투데이
What makes Century Therapeutics Inc. stock price move sharplyWeekly Loss Report & Weekly Breakout Stock Alerts - Newser
Detecting price anomalies in Century Therapeutics Inc. with AIJuly 2025 Intraday Action & Low Drawdown Investment Strategies - Newser
Using fundamentals and technicals on Century Therapeutics Inc.Weekly Market Summary & Safe Capital Allocation Plans - Newser
Century Therapeutics shares rise 4.38% premarket after Indaptus Therapeutics reported positive clinical trial results. - AInvest
Published on: 2025-09-05 05:14:49 - Newser
How to track smart money flows in Century Therapeutics Inc.2025 Institutional Moves & Safe Swing Trade Setup Alerts - Newser
Charles Schwab Investment Management Inc. Cuts Stake in Century Therapeutics, Inc. $IPSC - Defense World
Understanding Century Therapeutics Inc.’s price movement2025 Pullback Review & Short-Term Trading Opportunity Alerts - Newser
Applying Elliott Wave Theory to Century Therapeutics Inc.Bear Alert & Weekly Top Gainers Alerts - Newser
Is Century Therapeutics Inc. stock bottoming outMarket Trend Report & Growth Oriented Trading Recommendations - Newser
Should you wait for a breakout in Century Therapeutics Inc.July 2025 Momentum & Short-Term High Return Strategies - Newser
What data driven models say about Century Therapeutics Inc.’s futureJuly 2025 Review & Entry Point Confirmation Alerts - Newser
Is a relief rally coming for Century Therapeutics Inc. holders2025 Fundamental Recap & Safe Swing Trade Setup Alerts - Newser
Analyzing Century Therapeutics Inc. with risk reward ratio chartsMarket Performance Report & Growth Focused Investment Plans - Newser
How moving averages guide Century Therapeutics Inc. tradingJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - Newser
Reversal indicators forming on Century Therapeutics Inc. stockMarket Risk Report & Weekly High Return Stock Opportunities - Newser
Can Century Therapeutics Inc. ride the EV waveWeekly Stock Analysis & Weekly Breakout Stock Alerts - خودرو بانک
Can Century Therapeutics Inc. expand its profit margins2025 AllTime Highs & Long-Term Safe Investment Ideas - خودرو بانک
Sentiment Review: Can Century Therapeutics Inc. expand its profit margins2025 Market Trends & Community Consensus Trade Signals - خودرو بانک
Century Therapeutics shares rise 1.89% premarket after Fractyl Health expands its board of directors. - AInvest
Can Century Therapeutics Inc. rally from current levels2025 Year in Review & Stepwise Trade Signal Guides - Newser
What high frequency data says about Century Therapeutics Inc.July 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
Layoff Tracker: Novartis Continues Cutting Spree With 58 Sacked in New Jersey - BioSpace
Is Century Therapeutics Inc. showing insider buyingJuly 2025 Highlights & Weekly High Return Opportunities - خودرو بانک
What earnings revisions data tells us about Century Therapeutics Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
Using portfolio simulators with Century Therapeutics Inc. includedJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - Newser
How hedge fund analytics apply to Century Therapeutics Inc. stockProfit Target & Fast Gain Swing Trade Alerts - Newser
Century Therapeutics Inc. Added to Custom Quant Screener Today getLinesFromResByArray error: size == 0 - 강소기업뉴스
Using Ichimoku Cloud for Century Therapeutics Inc. technicalsMarket Movement Recap & Risk Controlled Stock Alerts - Newser
Earnings visualization tools for Century Therapeutics Inc.Weekly Gains Summary & Weekly Breakout Stock Alerts - Newser
Century Therapeutics Inc Stock (IPSC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):